Evotec (EVO) on Monday lowered its fiscal 2025 revenue guidance to be between 760 million euros ($884.9 million) and 800 million euros, down from the prior outlook of between 840 million euros and 880 million euros.
The company said the revised outlook reflects a shift in the revenue mix.
Shares of Evotect fell more than 13% in recent premarket trading Monday.
Price: 3.69, Change: -0.57, Percent Change: -13.38
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.